Aigen Investment Management LP purchased a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD – Free Report) during the 3rd quarter, HoldingsChannel reports. The firm purchased 238 shares of the medical instruments supplier’s stock, valued at approximately $357,000.
A number of other hedge funds also recently bought and sold shares of MTD. Family Firm Inc. acquired a new stake in Mettler-Toledo International in the second quarter valued at $25,000. Blue Trust Inc. raised its position in shares of Mettler-Toledo International by 242.9% during the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 17 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in Mettler-Toledo International during the third quarter worth approximately $37,000. Rothschild Investment LLC acquired a new position in Mettler-Toledo International in the second quarter valued at approximately $42,000. Finally, Itau Unibanco Holding S.A. acquired a new position in Mettler-Toledo International in the second quarter valued at approximately $42,000. Institutional investors and hedge funds own 95.07% of the company’s stock.
Insider Buying and Selling at Mettler-Toledo International
In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.94% of the stock is owned by company insiders.
Mettler-Toledo International Stock Down 4.7 %
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 40.37 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the stock. Stifel Nicolaus reduced their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. JPMorgan Chase & Co. upped their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Evercore ISI lifted their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Robert W. Baird decreased their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Finally, Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,338.75.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also
- Five stocks we like better than Mettler-Toledo International
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Investing In Preferred Stock vs. Common Stock
- Top-Performing Non-Leveraged ETFs This Year
- 5 discounted opportunities for dividend growth investors
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.